Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses

Current Opinion in Virology

Volumn 6, Issue 1, 2014, Pages 34-39

  Jin, Hong ^a   Chen, Zhongying ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS VACCINE; LIVE VACCINE;

ANTIGENICITY; ARTICLE; HUMAN; IMMUNOGENICITY; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVERSE GENETICS; SEASONAL INFLUENZA; VACCINE PRODUCTION; VIROGENESIS; ANIMAL; BIOTECHNOLOGY; CLASSIFICATION; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; ORTHOMYXOVIRUS;

ANIMALS; BIOTECHNOLOGY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; VACCINES, ATTENUATED;

EID: 84898732381     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2014.02.008     Document Type: Review

References (39)

1. J.J. Treanor et al. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok(R)) against influenza in healthy adults: a randomized, placebo-controlled trial Vaccine 29 2011 7733 7739
2. Z. Chen et al. Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines Virology 380 2008 354 362
3. E. Hoffmann et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66 J Virol 79 2005 11014 11021
4. H. Jin et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60 Virology 306 2003 18 24
5. P. Palese Influenza: old and new threats Nat Med 10 2004 S82 S87
6. J.K. Taubenberger, and J.C. Kash Influenza virus evolution, host adaptation, and pandemic formation Cell Host Microbe 7 2010 440 451
7. R. Gao et al. Human infection with a novel avian-origin influenza A (H7N9) virus N Engl J Med 368 2013 1888 1897
8. Q. Li et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China N Engl J Med 370 2014 520 532
9. B.R. Murphy, and K. Coelingh Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines Viral Immunol 15 2002 295 323
10. S. Basha et al. Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin Hum Immunol 72 2011 463 469
11. X. Cheng et al. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets J Infect Dis 208 2013 594 602
12. D.F. Hoft et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children J Infect Dis 204 2011 845 853
13. C.S. Ambrose, T. Yi, and J. Falloon An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years Influenza Other Respir Viruses 5 2011 389 397
14. R.B. Belshe et al. Live attenuated versus inactivated influenza vaccine in infants and young children N Engl J Med 356 2007 685 696
15. Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine - Colorado, December 2003 MMWR Morb Mortal Wkly Rep 53 2004 8 11
16. B. Lu et al. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics J Virol 79 2005 6763 6771
17. J.Y. Min et al. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys J Virol 84 2010 11950 11960
18. A.L. Suguitan Jr. et al. The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus Virology 395 2009 280 288
19. A.L. Suguitan Jr. et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets PLoS Med 3 2006 pe360
20. H. Jin et al. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99 Virology 336 2005 113 119
21. Z. Chen, H. Zhou, and H. Jin The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response Vaccine 28 2010 4079 4085
22. Q. Xu et al. Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets J Virol 84 2010 4936 4945
23. Z. Chen et al. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs J Virol 84 2010 44 51
24. W. Wang et al. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs J Virol 87 2013 4642 4649
25. C.R. Cotter, H. Jin, and Z. Chen A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity PLoS Pathog 10 2014 e1003831
26. W. Wang et al. Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage Vaccine 30 2011 872 878
27. Z. Chen, A. Aspelund, and H. Jin Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs Vaccine 26 2008 361 371
28. Q. Xu et al. Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus PLoS ONE 8 2013 pe76884
29. Z. Chen Development of high yield live attenuated H7N9 influenza vaccine that is highly effective against wild type virus challenge infection in ferrets J Virol 2014 (in press)
30. R.J. Connor et al. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates Virology 205 1994 17 23
31. K. Shinya et al. Avian flu: influenza virus receptors in the human airway Nature 440 2006 435 436
32. Z. Chen et al. The receptor binding specificity of the live attenuated influenza H2 and H6 vaccine viruses contributes to vaccine immunogenicity and protection in ferrets J Virol 86 2012 2780 2786
33. W. Wang et al. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets J Virol 84 2010 6570 6577
34. A. Doroshenko, and S.A. Halperin Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines) Expert Rev Vaccines 8 2009 679 688
35. K.R. Talaat et al. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults Influenza Other Respir Viruses 7 2012 66 73
36. R.A. Karron et al. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults Vaccine 27 2009 4953 4960
37. K.R. Talaat et al. An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults Vaccine 29 2011 3144 3148
38. K.R. Talaat et al. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults Vaccine 27 2009 3744 3753
39. R.A. Karron et al. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults J Infect Dis 199 2009 711 716